Published in 2014 Ann Oncol (2014) 25 (suppl 3): iii93-iii101.
Authors: R. Stupp, M. Brada, M. J. van den Bent, J.-C. Tonn, G. Pentheroudakis
This update covers recommendations for glioblastoma; anaplastic astrocytoma, oligoastrocytoma and oligodendroglioma; and diffuse glioma. The recommendations cover clinically relevant problems in: diagnosis and pathology, molecular markers, staging and risk assessment, treatment of newly diagnosed patients, treatment of patients with recurrent disease, personalised medicine, response evaluation plus follow-up and long-term implications.